Jennifer O'Neill

5PUBLICATIONS
12CO-AUTHORS
Major global burdens of diseasePharmaceutical delivery technologiesPsychiatry (incl. psychotherapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 31, 2026
Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience.

|Apr 27, 2026
Real-World Impact of Insurance Changes on Long-acting Cabotegravir Plus Rilpivirine Delivery.

|Mar 16, 2026
Scalability Metrics and Effort Requirements for a Long-Acting Injectable Antiretroviral Treatment Program.

Joshua P Havens, Jennifer O'Neill, Maureen Kubat

|Jul 24, 2025
Sustained HIV Viral Suppression 18 Months After the Last Dose of Long-acting Cabotegravir/Rilpivirine: A Case Report.

Shawnalyn W Sunagawa, Sara H Bares, Kimberly K Scarsi

|Jul 20, 2022
Convergent and divergent oscillatory aberrations during visuospatial processing in HIV-related cognitive impairment and Alzheimer's disease.

Chloe E Meehan, Christine M Embury, Alex I Wiesman

Pageof 1

Frequent Collaborators

4 joint publications

Sara H Bares

4 joint publications

Jennifer M Davis

3 joint publications

Shawnalyn W Sunagawa

3 joint publications

Joshua P Havens